From: Regulating ferroptosis by non-coding RNAs in hepatocellular carcinoma
miRNA | Expression/function | Targets | Effects on tumour | Refs. |
---|---|---|---|---|
miR-214-3p | ND/Tumor suppressor | ATF4 | Induce ferroptosis and inhibit HCC | [115] |
miR-23a-3p | ↑/Oncogene | ACSL4 | miR-23a-3p suppresses sorafenib-induced ferroptosis | [116] |
miR-552-5p | ↑/Oncogene | ACSL4 | Overexpression of ZNF8 reduces intracellular miR-552-5p levels and enhances sensitivity to ferroptosis. miR-552-5p inhibits ferroptosis by suppressing ACSL4 | [117] |
miR-142-3p | ↑/Oncogene | FTH1, TfR1, GPX4, ATF4 | Exosomal miR-142-3p from HBV-positive liver cancer cell promotes the progression of liver cancer by inducing ferroptosis of M1-type macrophages inhibiting SLC3A2 | [118] |
miR-142-3p | ↑/Oncogene | SLC3A2 | ↑HBV-infected M1-type macrophage ferroptosis through inhibiting SLC3A2;↑ development of HCC | [119] |
miR-21-5p | ↑/Oncogene | MELK | miR-21-5p inhibits the ferroptosis through activating AKT/mTOR signaling pathway via upregulating level of MELK | [120] |
miR-654-5p | -/Tumor suppressor | HSPB1 | miR-654-5p alleviate sorafenib resistance through inducing ferroptosis by targeting HSPB1 | [121] |
miR-612 | -/Tumor suppressor | CoQ10 | miR-612 inhibit tumour malignancy through inducing ferroptosis by decreasing CoQ10 and increasing cellular PUFA levels via the HADHA-mediated MVA pathway | [122] |
MiR-339-5p | ↑/Oncogene | FTH1 | miR-339 inhibits ferroptosis through suppressing ATG7-mediated autophagic degradation of FTH1 | [123] |
miR-4489 | -/Tumor suppressor | MUC1 | APOM suppress tumor and induces ferroptosis through down-regulating ferroptosis-inhibiting gene MUC1 via upregulating miR-4489 | [124] |